Omalizumab
2 results
Applied filters
The licence and supporting evidence for omalizumab biosimilar
6 October 2026Find information on Adcomfo and Omlyclo biosimilars, including indications, formulations, supporting evidence and differences.
Preparing to use omalizumab biosimilar
6 October 2026Find information to support planning, implementation and use of omalizumab biosimilars in NHS services.